Subscribe

Evergrande

19.70

+3.20 (+19.39%)

BYD

121.40

+13.20 (+12.20%)

Bydit

38.95

+3.45 (+9.72%)

Transsion

96.82

+7.82 (+8.79%)

Weibo

36.43

+2.78 (+8.26%)

BYD

116.24

+8.35 (+7.74%)

Ping An Good Doctor

99.25

-8.05 (-7.50%)

Meiya Pico

19.89

+1.21 (+6.48%)

Great Wall Motor

19.12

+1.11 (+6.16%)

Alibaba 

293.98

+17.05 (+6.16%)

CR Land

34.90

+1.95 (+5.92%)

Autohome

96.00

+5.30 (+5.84%)

IBI

87.55

+4.37 (+5.25%)

Topchoice Medical

213.70

+9.70 (+4.75%)

CanSinoBIO

345.00

+15.55 (+4.72%)

南微医学

233.00

+9.98 (+4.47%)

容百科技

29.74

+1.26 (+4.42%)

Fuyao

28.40

+1.20 (+4.41%)

Ali Health

18.88

+0.78 (+4.31%)

So Young

12.49

+0.51 (+4.26%)

Great Wall Motor

9.83

+0.40 (+4.24%)

Tsingtao

75.11

+3.03 (+4.20%)

Bloomage

133.79

+5.39 (+4.20%)

天准科技

31.88

-1.38 (-4.15%)

GSX Techedu

90.11

-3.87 (-4.12%)

Weichai Power

15.52

+0.58 (+3.88%)

Jafron

71.05

+2.65 (+3.87%)

Youzan

1.62

+0.06 (+3.85%)

Alibaba 

275.60

+10.20 (+3.84%)

Aier Eye Hospital

51.42

+1.89 (+3.82%)

Wantai

万泰生物

Wantai Bio-Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines

Wantai Bio-Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines, with the concept of "science-based, health-conscious", the aim of "quality for survival, scientific and technological innovation for development", and the pursuit of "to contribute to the cause of human health", to transform the achievements of biological technology into high-quality products to serve the public.

Wantai Bio-Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines

Wantai Bio-Pharmaceutical Co., Ltd. is a high-tech enterprise engaged in the research and development and production of biological diagnostic reagents and vaccines, with the concept of "science-based, health-conscious", the aim of "quality for survival, scientific and technological innovation for development", and the pursuit of "to contribute to the cause of human health", to transform the achievements of biological technology into high-quality products to serve the public.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded date

Apr 24, 1991

HQ location

Beijing, China

Legal name

北京万泰生物药业股份有限公司

Website

http://www.ystwt.com/

Number of Employees

501-1000

Related Companies
Bloomage

Bloomage

Haohai

Haohai

Fudan-Zhangjiang

Fudan-Zhangjiang

Fosun Pharma

Fosun Pharma

Burning Rock

Burning Rock

Briefing
Briefing · 1
Briefing
Oct 20, 2020 05:20 pm · VCbeat

Neusoft Medical Launches Ten New Products and Online Shopping Mall

Briefing
Briefing · 1
Briefing
Oct 19, 2020 02:17 pm · iYiou

Realcan's Digital Healthcare Branch Launches New Service Platform

Briefing
Briefing · 1
Briefing
Oct 19, 2020 10:03 am · CEC Capital

3D Medicines Diagnosis Raises CNY 1.5 Bn after Being Spun-off

Briefing
Briefing · 1
Briefing
Oct 16, 2020 04:24 pm · VCbeat

Beijing Immunochina Pharmaceutical Closes Series C+ at CNY 100 Mn

Domestic Substitution & a Heated Capital Market

Healthcare

Domestic Substitution & a Heated Capital Market
Aug 9, 2020 12:23 am
Tech for Global, Globalization Footprints of the Established and the New

Healthcare, Financials

Tech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 pm
Low-Carbon Industry Expansion - Key Studies From Chinese Companies

Healthcare, Financials

Low-Carbon Industry Expansion - Key Studies From Chinese Companies
May 28, 2020 12:40 pm
The Star Market Overview 1Q 2020

Healthcare, Financials

The Star Market Overview 1Q 2020
Apr 26, 2020 03:17 pm
COVID-19 and China

Healthcare, Financials

COVID-19 and China
Apr 19, 2020 06:36 pm
Briefing
Briefing · 1
Briefing
Oct 16, 2020 12:20 pm · VCbeat

Varian Medical Strikes CIIE with Digital Solution for Oncology

Briefing
Briefing · 1
Briefing
Sep 29, 2020 06:21 pm · Lieyunwang.com

GeneMind Biotech Closes Series B of CNY 140 Mn

Briefing
Briefing · 1
Briefing
Sep 28, 2020 08:25 pm · VCbeat

Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq

Briefing
Briefing · 1
Briefing
Sep 28, 2020 12:12 pm · Shunwei Capital

AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn

Briefing
Briefing · 1
Briefing
Sep 28, 2020 10:49 am · VCbeat

Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars

Briefing
Briefing · 1
Briefing
Sep 28, 2020 10:06 am · National Medical Products Administration

China's NMPA Reduces Paperwork for Inland Producers to Make Exotic Medical Devices

Briefing
Briefing · 1
Briefing
Sep 23, 2020 11:37 am · VCbeat

Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn

Briefing
Briefing · 1
Briefing
Sep 23, 2020 11:11 am · VCbeat

Tongshu Gene Closes Series B of Multi-Hundreds Millions

EO analysis
Briefing
Briefing · 1
Briefing
Sep 22, 2020 12:23 pm · China Trade News

Medical Cosmetic Manufacture IMEIK Goes Public, Raising CNY 3.57 Bn

Briefing
Briefing · 1
Briefing
Sep 18, 2020 12:24 pm · Tencent Tech

JD Health’s New Move on Hong Kong IPO

Briefing
Briefing · 1
Briefing
Sep 18, 2020 10:58 am · VCbeat

Biotech IMAB’s In-Process New Drug Enters Clinical Trials

Briefing
Briefing · 1
Briefing
Sep 15, 2020 01:58 pm · VCbeat

3D Printing Precision Medicine Industry Park Lands in Hunan

Briefing
Briefing · 1
Briefing
Sep 15, 2020 12:24 pm · VCbeat

Antibody Developer Biocytogen Closes Series D+ at CNY 790 Mn

Briefing
Briefing · 1
Briefing
Sep 15, 2020 11:54 am · VCbeat

Edge Medical Robotics Closes Pre Series B at Over CNY 100 Mn

Briefing
Briefing · 1
Briefing
Sep 14, 2020 06:28 pm · VCbeat

Nasdaq-listed Biotech ZLAB Passes the Hearing for Hong Kong IPO

Briefing
Briefing · 1
Briefing
Sep 14, 2020 06:22 pm · VCbeat

Genor Biopharma Passes the Hearing for Hong Kong IPO

Read more
Related Companies
Bloomage

Bloomage

Haohai

Haohai

Fudan-Zhangjiang

Fudan-Zhangjiang

Fosun Pharma

Fosun Pharma

Burning Rock

Burning Rock

EO analysis

EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.

We strive to make technology inclusive, accessible and transparent.

Join over 70,000 of your peers

Address

Beijing

9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China

Shanghai

A002, 5F, Ai Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China

New York

800 Third Ave, 28F, New York, NY 10022, USA

About

Careers

Principles

Team

Interviews with analysts

Cooperation with customers

Cooperation strategy

Products & prices

Customers & evaluation

Experience news with our apps

Copyright ©2020 EqualOcean.com. All rights reserved.